APA (7th ed.) Citation

Velji-Ibrahim, J., Woodard, J., Alden, J., & Abrams, G. A. (2025, January 10). FibroScan Discordance With Liver Biopsy Significantly Overestimates Advanced Fibrosis and Cirrhosis in MASLD Subjects With Class 3 Obesity: Implications for Resmetirom Eligibility. Journal of clinical gastroenterology. https://doi.org/10.1097/MCG.0000000000002132

Chicago Style (17th ed.) Citation

Velji-Ibrahim, Jena, Jordan Woodard, Jay Alden, and Gary A. Abrams. "FibroScan Discordance With Liver Biopsy Significantly Overestimates Advanced Fibrosis and Cirrhosis in MASLD Subjects With Class 3 Obesity: Implications for Resmetirom Eligibility." Journal of Clinical Gastroenterology 10 Jan. 2025. https://doi.org/10.1097/MCG.0000000000002132.

MLA (9th ed.) Citation

Velji-Ibrahim, Jena, et al. "FibroScan Discordance With Liver Biopsy Significantly Overestimates Advanced Fibrosis and Cirrhosis in MASLD Subjects With Class 3 Obesity: Implications for Resmetirom Eligibility." Journal of Clinical Gastroenterology, 10 Jan. 2025, https://doi.org/10.1097/MCG.0000000000002132.